Aortic stenosis classification: Difference between revisions
Line 110: | Line 110: | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | ||
* Aortic Vmax ≥ 4 m/s or mean ΔP ≥40 mmHg | * Aortic Vmax ≥ 4 m/s or mean ΔP ≥40 mmHg | ||
* AVA typically ≤ 1.0 cm<sup>2</sup> (or AVAi ≤ 0.6 cm<sup>2</sup>/m<sup>2<) but may be larger with mixed AS/AR | * AVA typically ≤ 1.0 cm<sup>2</sup> (or AVAi ≤ 0.6 cm<sup>2</sup>/m<sup>2</sup>) but may be larger with mixed AS/AR | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | ||
* LV diastolic dysfunction | * LV diastolic dysfunction | ||
Line 142: | Line 142: | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | ||
* AVA ≤1.0 cm<sup>2</sup> with aortic Vmax <4 m/s or mean ΔP <40 mmHg | * AVA ≤1.0 cm<sup>2</sup> with aortic Vmax <4 m/s or mean ΔP <40 mmHg | ||
* AVAi ≤0.6 cm<sup>2</sup>/ | * AVAi ≤0.6 cm<sup>2</sup>/m<sup>2</sup> and | ||
* Stroke volume index <25 ml/ | * Stroke volume index <25 ml/m<sup>2</sup> | ||
* Measured when patient is normotensive (systolic BP <140 mmHg) | * Measured when patient is normotensive (systolic BP <140 mmHg) | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" valign="top" | |
Revision as of 17:45, 6 December 2019
Resident Survival Guide |
Aortic Stenosis Microchapters |
Diagnosis |
---|
Treatment |
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
Transcatheter Aortic Valve Replacement (TAVR) |
Case Studies |
Aortic stenosis classification On the Web |
American Roentgen Ray Society Images of Aortic stenosis classification |
Directions to Hospitals Treating Aortic stenosis classification |
Risk calculators and risk factors for Aortic stenosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
According to the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, there are 4 stages of aortic stenosis based on the valve anatomy, valve hemodynamics, the left ventricular and vascular consequences of aortic obstruction, and the symptoms. The stages include at risk of AS, progressive hemodynamic obstruction, severe asymptomatic AS, and symptomatic AS.
Classification
40 cm2/m
According to the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, there are 4 stages of aortic stenosis based on the valve anatomy, valve hemodynamics, the left ventricular and vascular consequences of aortic obstruction, and the symptoms of the patient:
- A: Patient at risk of AS
- B: Progressive hemodynamic obstruction
- C: Severe asymptomatic AS
- D: Symptomatic AS
Hemodynamic severity is assessed by transaortic maximum velocity or mean pressure gradient in the presence of a normal transaortic flow rate. However, some patients with AS have a low transaortic flow rate due to:
- LV systolic dysfunction with a reduced LV ejection fraction (designated as D2)
- Small hypertrophied LV with a low stroke volume (designated as D3) [1]
Stage | Definition | Valve Anatomy | Valve Hemodynamics | Hemodynamic Consequences | Symptoms |
---|---|---|---|---|---|
A | At risk of AS |
|
|
|
|
B | Progressive AS |
|
|
|
|
C: | Asymptomatic severe AS | ||||
C1 | Asymptomatic severe AS |
|
|
|
|
C2 | Asymptomatic severe AS with LV dysfunction |
|
|
|
|
D: | Symptomatic severe AS | ||||
D1 | Symptomatic severe high-grade AS |
|
|
|
|
D2 | Symptomatic severe low-flow/low-gradient AS with reduced LVEF |
|
|
|
|
D3 | Symptomatic severe low-gradient AS with normal LVEF or paradoxical low-flow severe AS |
|
|
|
|
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J Thorac Cardiovasc Surg. 148 (1): e1–e132. doi:10.1016/j.jtcvs.2014.05.014. PMID 24939033.